Clinical Trial Update: Inhaled Fluticasone Effects on Upper Airway Patency in Obstructive Lung Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating inhaled fluticasone effects on upper airway patency in obstructive lung disease; the study was terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Obstructive Sleep Apnea

Drugs mentioned

• Fluticasone (fluticasone propionate)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Asthma, Chronic Obstructive Pulmonary Disease | Phase 4 | Status: TERMINATED | Results posted: 2020-02-05